| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 08/30/2000 | EP0612246B1 Pharmaceutical compositions of gallium complexes of 3-hydroxy-4-pyrones |
| 08/30/2000 | EP0248819B2 Recombinant fibroblast growth factors |
| 08/30/2000 | CN1265143A Prodn. of erythropoietin by endogenous gene activation |
| 08/30/2000 | CN1265109A Thiazolobenzoheterocycles, prepn. and medicines containing same |
| 08/30/2000 | CN1265102A Benzothia (oxa) diazol derivatives and their use as endothelin-receptor antagonists |
| 08/30/2000 | CN1265098A Heterocyclic derivatives which inhibit factor XA |
| 08/30/2000 | CN1265035A Method for inhibiting bone resorption |
| 08/30/2000 | CN1265033A Certain diarylimidaozle derivatives, new class of NPY speific ligands |
| 08/30/2000 | CN1265032A Therapeutic and dietary compsns. containing essential fatty acids and bioactive disulphides |
| 08/30/2000 | CN1264710A Modification and preparation of human interleukin 11 |
| 08/30/2000 | CN1264704A Novel spiro imidazoline compounds, their prepn. method and medicinal compsns. containing same |
| 08/30/2000 | CN1055924C Novel aminoalkyl benzoxazolinones and benzothizolinones and pharmaceutical compsns. and method for preparing same |
| 08/30/2000 | CN1055922C Lactone compound and process of prodn. thereof |
| 08/30/2000 | CN1055857C Chinese drugs for darkening hair and its prepn. method |
| 08/30/2000 | CN1055847C Medicine for curing deficiency of liver and kidney and its prodn. method |
| 08/29/2000 | US6111132 Compounds and methods for synthesis and therapy |
| 08/29/2000 | US6111094 Enhanced antisense modulation of ICAM-1 |
| 08/29/2000 | US6110974 Administering optically pure eutomer of adrenergic beta-2 agonist albuterol, while minimizing or eliminating side effects residing in the corresponding distomer |
| 08/29/2000 | US6110964 For treating arthritis, inflammatory bowel disease, crohn's disease, emphysema, acute respiratory distress syndrome, asthma chronic obstructive pulmonary disease, alzheimer's disease, organ transplant toxicity, cachexia, cancer |
| 08/29/2000 | US6110952 Preventing or treating nasal congestion, otitis media and sinusitis without undesired side effects, also asthma, pain, migraine, substance abuse and addiction, gastrointestinal disorder, ulcer, stomach hyperacidity |
| 08/29/2000 | US6110948 Treating of malignant tumor, tuberculosis, diabetes, blood dyscrasia, endocrine disease, infectious disease, or acquired immunodeficiency syndrome |
| 08/29/2000 | US6110947 An analgesic agent for treating stroke, abdominal pain; as antiinflammatory, diuretic, anesthetic or neuroprotective agents |
| 08/29/2000 | US6110945 An antiinflammatory agent inhibiting the binding of integrins to their ligands; in the prophylaxis for treating immune or inflammatory disorders |
| 08/29/2000 | US6110944 LTA4, hydrolase inhibitors |
| 08/29/2000 | US6110941 Compounds analogous to thalidomide from the class comprising piperidine-2,6-diones |
| 08/29/2000 | US6110940 Salts of an anti-migraine indole derivative |
| 08/29/2000 | US6110939 As a substance p antagonists treating tachykinin-mediated disease, asthma, central nervous system disorder |
| 08/29/2000 | US6110933 Amino acid derivatives and their use as phospholipase A2 inhibitor |
| 08/29/2000 | US6110932 Increase the level of endogenous growth hormone for the treatment and prevention of osteoporosis, congestive heart failure, frailty associated with aging, obesity; accelerating bone fracture repair, accelerating wound healing |
| 08/29/2000 | US6110924 Barbituric acid derivatives, processes for their production and pharmaceutical agents containing these compounds |
| 08/29/2000 | US6110920 Treatment of cardiovascular disorders and impotency |
| 08/29/2000 | US6110917 Selective serotonin (5-ht) receptor agonist for treating migraines, vasospasms |
| 08/29/2000 | US6110914 Spiroazabicyclic heterocyclic compounds |
| 08/29/2000 | US6110896 Peptidyl compounds and their therapeutic use |
| 08/29/2000 | US6110895 Method of promoting healing in skin grafts |
| 08/29/2000 | US6110894 Allosteric modulators of the NMDA receptor and their use in the treatment of CNS disorders and enhancement of CNS function |
| 08/29/2000 | US6110747 Compounds and methods for modulating tissue permeability |
| 08/29/2000 | US6110735 Method for the preparation of a viral vector by intermolecular homologous recombination |
| 08/29/2000 | US6110719 Phytase |
| 08/29/2000 | US6110701 DNA encoding precursor of interleukin-1β converting enzyme--related cysteine proteinase II (ICErel -II) |
| 08/29/2000 | US6110672 Peripheral nervous system specific sodium channels, DNA encoding therefor, crystallization, X-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using thereof |
| 08/29/2000 | US6110464 Polypeptides with amino acid sequences |
| 08/29/2000 | US6110460 Methods of using morphogen analogs |
| 08/29/2000 | CA2086754C Treatment of human lactation failure |
| 08/29/2000 | CA2015687C Human serum albomin fusion polypeptide |
| 08/29/2000 | CA2012628C New fluoro-4 benzoic derivatives, process for their preparation and pharmaceutical compositions containing them |
| 08/29/2000 | CA2012081C 2,5,6,7-tetranor-4,8-inter-m-phenylene pgi 2 derivatives |
| 08/24/2000 | WO2000049153A1 Fucosyl transferase gene |
| 08/24/2000 | WO2000049144A2 Pyk2 binding proteins |
| 08/24/2000 | WO2000049138A2 Pluripotential cells derived from embryonal teratocarcinoma cells and the nucleus of stomatic cells |
| 08/24/2000 | WO2000049137A2 Pluripotential cell derived from an embryonic stem cell and a nucleus of a somatic cell |
| 08/24/2000 | WO2000049135A2 Substrate for cell growth |
| 08/24/2000 | WO2000049043A2 Human lipid-associated proteins |
| 08/24/2000 | WO2000049037A1 Growth hormone secretagogues |
| 08/24/2000 | WO2000049030A1 5-fluorouridine derivatives and anticancer agents containing the same as the active ingredient |
| 08/24/2000 | WO2000049015A1 Pyridine compounds and their pharmaceutical use |
| 08/24/2000 | WO2000049011A1 Prothease inhibitors |
| 08/24/2000 | WO2000049008A1 Di- and tripeptide nitrile derivatives as inhibitors of cathepsin l and cathepsin s |
| 08/24/2000 | WO2000049007A1 Acetamido acetonitrile derivatives as inhibitors of cathepsin l and/or cathepsin s |
| 08/24/2000 | WO2000049005A1 Bicyclic compounds and their use as integrin receptor ligands |
| 08/24/2000 | WO2000048996A2 β-ALANINE DERIVATIVES |
| 08/24/2000 | WO2000048994A1 Thioamide derivatives |
| 08/24/2000 | WO2000048992A1 Acylated aminoacetonitriles as cysteine protease inhibitors |
| 08/24/2000 | WO2000048989A1 Mevinolin derivatives |
| 08/24/2000 | WO2000048643A1 Biodegradable, injectable oligomer-polymer composition |
| 08/24/2000 | WO2000048634A1 Percutaneous absorption preparations of compound having angiotensin ii receptor antagonism |
| 08/24/2000 | WO2000048627A1 Inhibitors of separin, method for identifying them and uses |
| 08/24/2000 | WO2000048625A2 Inhibitors for use in hemostasis and immune function |
| 08/24/2000 | WO2000048623A1 Novel amide derivatives as growth hormone secretagogues |
| 08/24/2000 | WO2000048617A2 Connective tissue softening |
| 08/24/2000 | WO2000048616A1 High molecular weight extracts of $i(convolvulus arvensis )(field bindweed) |
| 08/24/2000 | WO2000048613A1 Method of treatment of equine disease |
| 08/24/2000 | WO2000048610A1 Chemical compounds |
| 08/24/2000 | WO2000048609A1 Chemical compounds |
| 08/24/2000 | WO2000048608A1 Cerebrovascular regeneration/reconstruction promoters and nerve tissue secondary degeneration inhibitors comprising ginsenoside rb¿1? |
| 08/24/2000 | WO2000048603A1 DIBENZO-AZEPINE DERIVATIVES AS αV INTEGRIN RECEPTOR ANTAGONISTS |
| 08/24/2000 | WO2000048602A1 Intermittent claudication therapeutic drugs comprising pyrroloazepines |
| 08/24/2000 | WO2000048597A1 Systemic use of 5-ht3 receptor antagonists against rheumatic inflammatory processes |
| 08/24/2000 | WO2000048595A1 A novel anti-angiogenic agent comprising at least one kringle region and an upstream pre-activation domain of plasminogen |
| 08/24/2000 | WO2000048593A1 Epoxide hydrolase complexes and methods therewith |
| 08/24/2000 | WO2000048590A1 Substituted stilbene compounds with vascular damaging activity |
| 08/24/2000 | WO2000048587A1 Combinations of formoterol and fluticasone propionate for asthma |
| 08/24/2000 | WO2000048586A1 Remedies |
| 08/24/2000 | WO2000048572A1 Phosphocholine linked prodrug derivatives |
| 08/24/2000 | WO2000048571A1 Spontaneously dispersible n-benzoyl staurosporine compositions |
| 08/24/2000 | WO2000048447A2 Composition for treatment of external secretion disorders except hypolacrimation |
| 08/24/2000 | WO2000048446A2 Use of antagonists of pg-e for the treatment of neuropathic pain |
| 08/24/2000 | WO2000037470A8 Antihistaminic spiro compounds |
| 08/24/2000 | WO2000031051B1 Quinoline and quinoxaline compounds as pdgf-receptor and/or lck tyrosine kinase inhibitors |
| 08/24/2000 | WO2000024362A3 Δ9 tetrahydrocannabinol (δ9 thc) solution metered dose inhalers and methods of use |
| 08/24/2000 | WO2000022113A9 ENZYMATIC SYNTHESIS OF ssDNA |
| 08/24/2000 | WO2000021987A9 A method of identifying modulators of cell surface membrane receptors useful in the treatment of disease |
| 08/24/2000 | WO2000020025A9 Akt compositions for enhancing survival of cells |
| 08/24/2000 | WO2000018917A9 α-SYNUCLEIN SUPER-MUTANTS ACCELERATE α-SYNUCLEIN AGGREGATION |
| 08/24/2000 | WO2000015246A9 Regulation of lung tissue by hedgehog-like polypeptides, and formulations and uses related thereto |
| 08/24/2000 | WO2000004917A9 USE OF HC gp-39 IN IMMUNE DISEASES |
| 08/24/2000 | WO1999034763A3 Pharmaceutical compositions comprising thiram for inhibiting angiogenesis |
| 08/24/2000 | WO1996012697A9 Calcium receptor-active compounds |
| 08/24/2000 | DE4193302C2 Verwendung rekombinanter Antikörper spezifisch für TNF-alpha Using recombinant antibody specific for TNF-alpha |
| 08/24/2000 | DE19908753A1 Oligomer-polymer composition containing biodegradable polymers of hydroxycarboxylic acids, useful as injectable implant for administration of various drugs |